Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon”

637 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 637 results

Testing effectiveness (Phase 2)Study completedNCT01930097
What this trial is testing

Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 12
Not applicableUnknownNCT04383197
What this trial is testing

Exercise and GLP-1 RA on Insulin Secretion

Who this might be right for
Type 2 Diabetes
University of Copenhagen 30
Not applicableStudy completedNCT02280837
What this trial is testing

Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?

Who this might be right for
Coronary Artery Disease
Sapporo Medical University 190
Not applicableStudy completedNCT03526445
What this trial is testing

Hepatic Metabolic Changes in Response to Glucagon Infusion

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseTotal PancreatectomyDiabetes Mellitus
Steno Diabetes Center Copenhagen 27
Early research (Phase 1)Study completedNCT02237053
What this trial is testing

Effects of Glucagon Administration on Energy Expenditure

Who this might be right for
HyperglucagonemiaObesity
AdventHealth Translational Research Institute 6
Not applicableLooking for participantsNCT06069622
What this trial is testing

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Who this might be right for
Overweight and Obesity
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT06640972
What this trial is testing

Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists

Who this might be right for
TriglyceridesWeight Gain TrajectoryCholesterol, Elevated
Response Pharmaceuticals 68
Not applicableStudy completedNCT01483651
What this trial is testing

Physiologic Response to Glucagon at Varying Insulin Levels

Who this might be right for
Type 1 Diabetes Mellitus
Legacy Health System 11
Not applicableUnknownNCT00704795
What this trial is testing

Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes

Who this might be right for
HyperglucagonemiaHyperglycemiaDiabetes Mellitus
University Hospital, Gentofte, Copenhagen 20
Not applicableNot Yet RecruitingNCT06982378
What this trial is testing

GLP-1 RA on Liver OMICS in MASLD

Who this might be right for
NAFLDDiabetesObesity
Medical College of Wisconsin 30
Post-approval studies (Phase 4)Study completedNCT02276196
What this trial is testing

Effect of LIXIsenatide on the Renal System

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes Mellitus+1 more
Amsterdam UMC, location VUmc 40
Post-approval studies (Phase 4)Study completedNCT04053712
What this trial is testing

Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia
Steno Diabetes Center Copenhagen 13
Not applicableStudy completedNCT06038734
What this trial is testing

Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

Who this might be right for
Delayed Gastric EmptyingGastroparesis
University of North Carolina, Chapel Hill 108
Testing effectiveness (Phase 2)Looking for participantsNCT05822609
What this trial is testing

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Who this might be right for
Diabetic Kidney DiseaseType 1 Diabetes
University of Washington 60
Large-scale testing (Phase 3)Study completedNCT02664441
What this trial is testing

Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity

Who this might be right for
Hypothalamic Obesity
Seattle Children's Hospital 42
Testing effectiveness (Phase 2)Study completedNCT02733588
What this trial is testing

Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

Who this might be right for
HypoglycemiaComplications of Bariatric Procedures
Xeris Pharmaceuticals 8
Post-approval studies (Phase 4)WithdrawnNCT01674283
What this trial is testing

Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization

Who this might be right for
Women With Fertility Disorder
Clinique Ovo
Early research (Phase 1)Study completedNCT02673554
What this trial is testing

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 30
Early research (Phase 1)Study completedNCT01373450
What this trial is testing

Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 12
Large-scale testing (Phase 3)Study completedNCT01584232
What this trial is testing

Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 361
Load More Results